Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.6 USD | -2.54% | +1.37% | -14.59% |
May. 13 | Theravance Narrows Q1 Loss as Revenue Rises; Shares Rise After-hours | MT |
May. 13 | Transcript : Theravance Biopharma, Inc., Q1 2024 Earnings Call, May 13, 2024 |
Financials (USD)
Sales 2024 * | 78.81M | Sales 2025 * | 101M | Capitalization | 467M |
---|---|---|---|---|---|
Net income 2024 * | -18M | Net income 2025 * | 1M | EV / Sales 2024 * | 5.92 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 4.64 x |
P/E ratio 2024 * |
-22.6
x | P/E ratio 2025 * |
46.3
x | Employees | 99 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.33% |
Latest transcript on Theravance Biopharma, Inc.
1 day | -2.54% | ||
1 week | +1.37% | ||
Current month | +13.74% | ||
1 month | -0.93% | ||
3 months | +9.09% | ||
6 months | -6.71% | ||
Current year | -14.59% |
Managers | Title | Age | Since |
---|---|---|---|
Rick Winningham
CEO | Chief Executive Officer | 64 | 13-06-30 |
Aziz Sawaf
DFI | Director of Finance/CFO | 42 | 14-05-31 |
Stuart Knight
CTO | Chief Tech/Sci/R&D Officer | - | 14-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Dean Mitchell
BRD | Director/Board Member | 68 | 14-05-31 |
Eran Broshy
BRD | Director/Board Member | 65 | 14-06-01 |
Director/Board Member | 59 | 20-06-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 0 M€ | 0.00% | - | |
0.06% | 0 M€ | 0.00% | - | |
0.03% | 746 M€ | -.--% | - | |
0.02% | 430 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 9.6 | -2.54% | 381,711 |
24-05-15 | 9.85 | +4.90% | 285,699 |
24-05-14 | 9.39 | -1.98% | 301,145 |
24-05-13 | 9.58 | +2.13% | 189,269 |
24-05-10 | 9.38 | -0.95% | 339,462 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.59% | 467M | |
+32.36% | 694B | |
+30.04% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.45% | 239B | |
+10.45% | 209B | |
-3.11% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- TBPH Stock